Search

Your search keyword '"Lamprecht, Peter"' showing total 457 results

Search Constraints

Start Over You searched for: Author "Lamprecht, Peter" Remove constraint Author: "Lamprecht, Peter"
457 results on '"Lamprecht, Peter"'

Search Results

1. Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study

4. The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial

5. Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial

6. Autoimmune pre-disease

8. Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study

9. The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 195 GCA patients

14. Data quality and patient characteristics in European ANCA-associated vasculitis registries: data retrieval by federated querying

15. The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 266 AAV-patients

17. The Joint Vasculitis Registry in German-speaking countries (GeVas) – a prospective, multicenter registry for the follow-up of long-term outcomes in vasculitis

19. The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial

21. Characteristics and outcome of ANCA-associated vasculitides induced by anti-thyroid drugs: a multicentre retrospective case-control study

22. Characteristics and outcome of ANCA-associated vasculitides induced by anti-thyroid drugs: a multicenter retrospective case-control study

26. COVID-19 pandemic impairs medical care of vasculitis patients in Germany: Results of a national patient survey

27. GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis

28. Low concentrations of C5a complement receptor antibodies are linked to disease activity and relapse in ANCA ‐associated vasculitis

35. Clinical Characteristics and Outcome of ANCA-Associated Vasculitides Induced by Anti-Thyroid Drugs: A Multicenter Retrospective Cohort Study

36. Clustering model of 23 antibodies against G protein-coupled receptors (GPCR) identifies two different subsets of ANCA-associated vasculitis (AAV) with different prognosis

37. Das Gemeinsame Vaskulitis-Register im deutschsprachigen Raum (GeVas) – eine Subgruppenanalyse der 131 RZA-Patienten

38. Nomenclature of Cutaneous Vasculitis: Dermatologic Addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

40. Low Concentrations of C5a Complement Receptor Antibodies Are Linked to Disease Activity and Relapse in Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis.

41. Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis

42. Infektiöse Arthropathien

45. Erkrankungen von Knochen, Muskeln und Gelenken

47. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis

48. Additional file 1 of Both T and B cells are indispensable for the development of a PBMC transfer-induced humanized mouse model for SSc

49. The neutrophil: A key resourceful agent in immune‐mediated vasculitis.

Catalog

Books, media, physical & digital resources